latimes.com: "Avastin (bevacizumab) is a so-called biological therapy and the first drug approved by the FDA that was designed to inhibit growth of blood vessels feeding tumors."
Subscribe to:
Post Comments (Atom)
Search and find pharmaceutical and medical information fast.Browse and read current and archived drug news
0 comments:
Post a Comment